Aimei Health Technology Co., Ltd. Material Event - What Happened

Hey there! Let's break down some important news from Aimei Health Technology Co., Ltd. in a way that makes sense, without all the confusing business talk. Think of this as me explaining a news story to you over coffee.

---

1. What happened? (The actual event, in plain English)

Alright, so Aimei Health Technology, which is a "Special Purpose Acquisition Company" (SPAC) – basically a company formed to merge with or acquire another private company and bring it public – just announced they've pushed back the deadline to complete their first big deal. They're trying to merge with another company called United Hydrogen Group Inc.

They paid a fee to extend this deadline by another month, from January 6, 2026, to February 6, 2026. To cover this fee, they issued a special loan (a "promissory note") to their main backer (the "Sponsor") and United Hydrogen. Think of it like a company needing more time to close a big acquisition, and the main investors are chipping in to buy that extra time.

2. When did it happen?

This news officially broke on January 5, 2026. The extension pushes their deadline to February 6, 2026.

3. Why did it happen? (Context and background)

So, why the big change? Aimei Health Technology is what's known as a "SPAC" (Special Purpose Acquisition Company). Their whole purpose is to find a private company and merge with it, essentially bringing that private company public without the traditional IPO process. They have a set amount of time to do this, and if they don't, they usually have to return money to investors.

It seems they need more time to finalize their planned merger with United Hydrogen Group Inc. This is actually the fourteenth time they've extended this deadline, which suggests the deal is proving quite complex or challenging to close.

To get this extension, they had to deposit about $34,330.96 into a special trust account for their public shareholders. This money essentially buys them another month. To fund this payment, they issued a "promissory note" (think of it as an IOU) for the same amount to their main backer (Aimei Health Ltd, their "Sponsor") and to United Hydrogen Group Inc. itself. This shows both parties are still committed to making the deal happen.

4. Why does this matter? (Impact and significance)

Okay, so why should you care about this? This isn't just some boring corporate memo. This extension means Aimei is still actively working to complete its merger with United Hydrogen. For investors, it means the deal isn't dead yet, but the fact that it's the 14th extension could be a red flag. It suggests there might be ongoing hurdles or delays in getting the deal done, which can make investors nervous.

The promissory note is a way for the company to get the cash needed for the extension without dipping into its main funds. It also means the Sponsor and United Hydrogen are putting more money into the deal, showing their continued commitment. However, if the deal doesn't go through, this money might not be repaid in cash, but could convert into shares, potentially diluting existing shareholders. It's a big pivot that could change how successful they are in the future, and how they stack up against other companies in the health tech space. It's a moment where the company is either taking a big leap forward or facing a significant hurdle.

5. Who is affected? (Employees, customers, investors, etc.)

Who's going to feel the ripples from this?

• Employees: Not directly mentioned in the filing, but continued uncertainty about the merger could affect future plans.
• Customers: Not directly affected by this administrative extension.
• Other Businesses (Partners/Competitors): United Hydrogen Group Inc. is directly involved as the target company. The Sponsor (Aimei Health Ltd) is also directly involved by providing funds.
• Investors (that's you!): This is a big deal for anyone who owns Aimei stock, or is thinking about it.
  • It confirms the company is still pursuing the merger with United Hydrogen.
  • The repeated extensions (14th!) might make some investors nervous about the deal's viability or the company's ability to execute.
  • The promissory note means the Sponsor and United Hydrogen are essentially lending money to the SPAC. They have the option to convert this loan into "private units" (which are like a package of shares and rights to more shares) at a price of $10.00 per unit if the merger goes through. This could potentially dilute the ownership of existing public shareholders if they convert, meaning your slice of the company pie might get a little smaller.

6. What happens next? (Immediate and future implications)

So, what's the next chapter in this story? Aimei Health Technology will continue to work towards finalizing its business combination (merger) with United Hydrogen Group Inc. The new deadline is February 6, 2026. We'll be watching to see if they can finally close this deal by the new deadline, or if another extension (or even a termination of the deal) will be announced. It's not a one-and-done thing; it's a process that will unfold over time.

7. What should investors/traders know? (Practical takeaways)

Alright, for those of us looking at our portfolios:

• SPACs and Deadlines: This is a classic SPAC situation. SPACs have a limited time to complete an acquisition. Repeated extensions, especially this many (14th!), can signal difficulties in closing a deal, which can make investors wary.
• Promissory Note Details: The fact that the Sponsor and the target company (United Hydrogen) are funding the extension via a promissory note shows their continued commitment. However, the option for them to convert this loan into shares at $10.00 per unit before the merger means potential dilution for existing shareholders if the deal closes and they exercise this option.
• Uncertainty Continues: While the extension keeps the deal alive, it also prolongs the uncertainty. Keep an eye on any further announcements regarding the merger's progress or potential roadblocks.
• Focus on the Merger: The ultimate success of this SPAC hinges on the completion and success of the merger with United Hydrogen. This extension is just a step in that ongoing process.
• Do your own homework: This report gives you the basics, but always dig a little deeper if you're thinking of buying or selling. Think about your own investment goals and how much risk you're comfortable with.